Cargando…

Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience

BACKGROUND: Epidemiological studies commonly identify the clinical characteristics and survival outcomes of patients with breast cancer at five years. Our study aims to describe the sociodemographic, clinicopathological characteristics and determine the long-term event-free survival (EFS) and overal...

Descripción completa

Detalles Bibliográficos
Autores principales: De-la-Cruz-Ku, Gabriel, Luyo, Marianne, Morante, Zaida, Enriquez, Daniel, Möller, Mecker G., Chambergo-Michilot, Diego, Flores, Lucero, Luque, Renato, Saavedra, Antonella, Eyzaguirre-Sandoval, Miguel E., Luján-Peche, María G., Noel, Naysha, Calderon, Hafid, Razuri, Cesar, Fuentes, Hugo A., Cotrina, Jose Manuel, Neciosup, Silvia P., Araujo, Jhajaira, Lema, Alexandra, Pinto, Joseph, Gomez, Henry L., Valcarcel, Bryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444821/
https://www.ncbi.nlm.nih.gov/pubmed/32833983
http://dx.doi.org/10.1371/journal.pone.0237811
_version_ 1783573872330670080
author De-la-Cruz-Ku, Gabriel
Luyo, Marianne
Morante, Zaida
Enriquez, Daniel
Möller, Mecker G.
Chambergo-Michilot, Diego
Flores, Lucero
Luque, Renato
Saavedra, Antonella
Eyzaguirre-Sandoval, Miguel E.
Luján-Peche, María G.
Noel, Naysha
Calderon, Hafid
Razuri, Cesar
Fuentes, Hugo A.
Cotrina, Jose Manuel
Neciosup, Silvia P.
Araujo, Jhajaira
Lema, Alexandra
Pinto, Joseph
Gomez, Henry L.
Valcarcel, Bryan
author_facet De-la-Cruz-Ku, Gabriel
Luyo, Marianne
Morante, Zaida
Enriquez, Daniel
Möller, Mecker G.
Chambergo-Michilot, Diego
Flores, Lucero
Luque, Renato
Saavedra, Antonella
Eyzaguirre-Sandoval, Miguel E.
Luján-Peche, María G.
Noel, Naysha
Calderon, Hafid
Razuri, Cesar
Fuentes, Hugo A.
Cotrina, Jose Manuel
Neciosup, Silvia P.
Araujo, Jhajaira
Lema, Alexandra
Pinto, Joseph
Gomez, Henry L.
Valcarcel, Bryan
author_sort De-la-Cruz-Ku, Gabriel
collection PubMed
description BACKGROUND: Epidemiological studies commonly identify the clinical characteristics and survival outcomes of patients with breast cancer at five years. Our study aims to describe the sociodemographic, clinicopathological characteristics and determine the long-term event-free survival (EFS) and overall survival (OS) of a Peruvian population with triple-negative breast cancer. METHODS: We reviewed the medical records of new cases treated at a single institution in the period 2000–2014. The survival analysis included patients with stages I-IV. Survival estimates at 10 years were calculated with the Kaplan-Meier method and compared with the Log-rank test. We further used multivariate Cox regression analysis to calculate prognostic factors of recurrence and mortality. RESULTS: Among the 2007 patients included, the median age at diagnosis was 49 years (19–95 years). Most patients presented histologic grade III (68.7%), tumor stage II (34.2%), and III (51.0%) at diagnosis. Local and distant relapse was present in 31.9 and 51.4% of the patients, respectively. The most frequent sites of metastasis were the lungs (14.5%), followed by bone (9.7%), brain (9.6%), and liver (7.9%). The median follow-up was 153 months. At 3, 5, and 10 years, the EFS of the population was 55%, 49%, and 41%, respectively, while the OS was 64%, 56%, and 47%, respectively. Moreover, an N3 lymph node status was the most important prognostic factor for both disease relapse (HR: 2.54, 95% CI: 2.05–3.15) and mortality (HR: 2.51, 95% CI: 2.01–3.14) at ten years. An older age and higher T staging were associated with a worse OS, while patients who received radiotherapy and adjuvant chemotherapy had better survival rates. CONCLUSION: The sociodemographic features of Peruvian patients with TNBC are similar to those of other populations. However, our population was diagnosed at more advanced clinical stages, and thus, EFS and OS were lower than international reports while prognostic factors were similar to previous studies.
format Online
Article
Text
id pubmed-7444821
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-74448212020-08-27 Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience De-la-Cruz-Ku, Gabriel Luyo, Marianne Morante, Zaida Enriquez, Daniel Möller, Mecker G. Chambergo-Michilot, Diego Flores, Lucero Luque, Renato Saavedra, Antonella Eyzaguirre-Sandoval, Miguel E. Luján-Peche, María G. Noel, Naysha Calderon, Hafid Razuri, Cesar Fuentes, Hugo A. Cotrina, Jose Manuel Neciosup, Silvia P. Araujo, Jhajaira Lema, Alexandra Pinto, Joseph Gomez, Henry L. Valcarcel, Bryan PLoS One Research Article BACKGROUND: Epidemiological studies commonly identify the clinical characteristics and survival outcomes of patients with breast cancer at five years. Our study aims to describe the sociodemographic, clinicopathological characteristics and determine the long-term event-free survival (EFS) and overall survival (OS) of a Peruvian population with triple-negative breast cancer. METHODS: We reviewed the medical records of new cases treated at a single institution in the period 2000–2014. The survival analysis included patients with stages I-IV. Survival estimates at 10 years were calculated with the Kaplan-Meier method and compared with the Log-rank test. We further used multivariate Cox regression analysis to calculate prognostic factors of recurrence and mortality. RESULTS: Among the 2007 patients included, the median age at diagnosis was 49 years (19–95 years). Most patients presented histologic grade III (68.7%), tumor stage II (34.2%), and III (51.0%) at diagnosis. Local and distant relapse was present in 31.9 and 51.4% of the patients, respectively. The most frequent sites of metastasis were the lungs (14.5%), followed by bone (9.7%), brain (9.6%), and liver (7.9%). The median follow-up was 153 months. At 3, 5, and 10 years, the EFS of the population was 55%, 49%, and 41%, respectively, while the OS was 64%, 56%, and 47%, respectively. Moreover, an N3 lymph node status was the most important prognostic factor for both disease relapse (HR: 2.54, 95% CI: 2.05–3.15) and mortality (HR: 2.51, 95% CI: 2.01–3.14) at ten years. An older age and higher T staging were associated with a worse OS, while patients who received radiotherapy and adjuvant chemotherapy had better survival rates. CONCLUSION: The sociodemographic features of Peruvian patients with TNBC are similar to those of other populations. However, our population was diagnosed at more advanced clinical stages, and thus, EFS and OS were lower than international reports while prognostic factors were similar to previous studies. Public Library of Science 2020-08-24 /pmc/articles/PMC7444821/ /pubmed/32833983 http://dx.doi.org/10.1371/journal.pone.0237811 Text en © 2020 De-la-Cruz-Ku et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
De-la-Cruz-Ku, Gabriel
Luyo, Marianne
Morante, Zaida
Enriquez, Daniel
Möller, Mecker G.
Chambergo-Michilot, Diego
Flores, Lucero
Luque, Renato
Saavedra, Antonella
Eyzaguirre-Sandoval, Miguel E.
Luján-Peche, María G.
Noel, Naysha
Calderon, Hafid
Razuri, Cesar
Fuentes, Hugo A.
Cotrina, Jose Manuel
Neciosup, Silvia P.
Araujo, Jhajaira
Lema, Alexandra
Pinto, Joseph
Gomez, Henry L.
Valcarcel, Bryan
Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience
title Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience
title_full Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience
title_fullStr Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience
title_full_unstemmed Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience
title_short Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience
title_sort triple-negative breast cancer in peru: 2000 patients and 15 years of experience
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444821/
https://www.ncbi.nlm.nih.gov/pubmed/32833983
http://dx.doi.org/10.1371/journal.pone.0237811
work_keys_str_mv AT delacruzkugabriel triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT luyomarianne triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT morantezaida triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT enriquezdaniel triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT mollermeckerg triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT chambergomichilotdiego triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT floreslucero triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT luquerenato triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT saavedraantonella triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT eyzaguirresandovalmiguele triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT lujanpechemariag triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT noelnaysha triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT calderonhafid triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT razuricesar triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT fuenteshugoa triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT cotrinajosemanuel triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT neciosupsilviap triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT araujojhajaira triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT lemaalexandra triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT pintojoseph triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT gomezhenryl triplenegativebreastcancerinperu2000patientsand15yearsofexperience
AT valcarcelbryan triplenegativebreastcancerinperu2000patientsand15yearsofexperience